Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.84B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 3 |
Nike
NKE
|
+$1.17B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$922M |
| 5 |
Hewlett Packard
HPE
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.14B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.13B |
| 3 |
Broadcom
AVGO
|
+$625M |
| 4 |
UnitedHealth
UNH
|
+$584M |
| 5 |
Mastercard
MA
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.22% |
| 2 | Financials | 9.76% |
| 3 | Consumer Discretionary | 7.43% |
| 4 | Healthcare | 7.41% |
| 5 | Industrials | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
NatWest
NWG
$77.3B
| $77.2M | 0.01% |
6,474,908
+455,538
| +8% | +$5.11M |
|
927
Factset
FDS
$9.59B
| $77.1M | 0.01% |
169,635
-53,012
| -24% | -$24.1M |
|
928
CALL
JD.com
JD
$44.5B
| $77M | 0.01% |
1,872,100
-1,360,100
| -42% | -$54.6M |
|
929
MGIC Investment
MTG
$6.27B
| $76.9M | 0.01% |
3,103,366
+195,895
| +7% | +$4.74M |
|
930
Ulta Beauty
ULTA
$23B
| $76.9M | 0.01% |
209,763
-32,754
| -14% | -$12.5M |
|
931
BridgeBio Pharma
BBIO
$15.7B
| $76.9M | 0.01% |
2,223,308
+188,119
| +9% | +$6.34M |
|
932
PUT
ConocoPhillips
COP
$145B
| $76.8M | 0.01% |
731,400
+113,500
| +18% | +$11.3M |
|
933
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.63B
| $76.8M | 0.01% |
582,900
-64,800
| -10% | -$8.69M |
|
|
WCC
934
WESCO International
WCC
$17.6B
| $76.7M | 0.01% |
493,573
+315,390
| +177% | +$56.4M |
|
935
Revolution Medicines
RVMD
$38.8B
| $76.5M | 0.01% |
2,164,501
-465,651
| -18% | -$18.9M |
|
936
Hershey
HSY
$35.7B
| $76.5M | 0.01% |
447,072
-146,641
| -25% | -$24M |
|
937
Samsara
IOT
$22.5B
| $76.3M | 0.01% |
1,990,004
-239,398
| -11% | -$11.1M |
|
938
Merit Medical Systems
MMSI
$5.11B
| $76M | 0.01% |
719,313
+103,878
| +17% | +$10.7M |
|
939
Affirm
AFRM
$26.2B
| $76M | 0.01% |
1,682,614
+348,852
| +26% | +$20.7M |
|
|
CPRX
940
DELISTED
Catalyst Pharmaceutical
CPRX
| $76M | 0.01% |
3,135,473
+333,100
| +12% | +$7.5M |
|
941
Cullen/Frost Bankers
CFR
$10.5B
| $75.8M | 0.01% |
605,697
+230,993
| +62% | +$31M |
|
942
Natural Resource Partners
NRP
$1.28B
| $75.7M | 0.01% |
728,873
-9,400
| -1% | -$984K |
|
943
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.48B
| $75.7M | 0.01% |
2,094,816
-35,857
| -2% | -$1.3M |
|
944
Goldman Sachs BDC
GSBD
$993M
| $75.7M | 0.01% |
6,511,355
| – | – |
|
945
Kinsale Capital Group
KNSL
$8.21B
| $75.7M | 0.01% |
155,540
-11,165
| -7% | -$5.01M |
|
946
TG Therapeutics
TGTX
$7.07B
| $75.7M | 0.01% |
1,919,416
+345,059
| +22% | +$11.6M |
|
947
Align Technology
ALGN
$12.4B
| $75.6M | 0.01% |
476,126
-54,847
| -10% | -$10.8M |
|
948
Range Resources
RRC
$9.43B
| $75.6M | 0.01% |
1,893,091
-228,340
| -11% | -$8.78M |
|
|
PR
949
Permian Resources
PR
$17.5B
| $75.5M | 0.01% |
5,452,127
+852,347
| +19% | +$12.2M |
|
950
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.56B
| $75.5M | 0.01% |
2,840,000
-1,775,000
| -38% | -$47.1M |
|
Similar funds
Goldman Sachs's Q1 2025 Portfolio in Review
As of Q1 2025, Goldman Sachs held 6,539 positions worth $618B, down 2.6% from $634B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs's Q1 2025 filing shows 547 new, 2,374 increased, 2,724 reduced and 514 closed positions. Its largest new stake was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M. The largest sale was TC Energy, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q1 2025 buy was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M.
- Goldman Sachs added most to iShares Russell 2000 ETF in Q1 2025, an estimated $1.84B increase.
- Goldman Sachs's biggest Q1 2025 reduction was TC Energy, cutting an estimated $1.14B.
- Goldman Sachs fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $242M.
- Goldman Sachs's ten largest holdings make up 20% of its $618B portfolio in Q1 2025.
- Goldman Sachs opened 547 new positions and closed 514 in Q1 2025.
- Goldman Sachs's portfolio value fell 2.6% quarter-over-quarter to $618B.
Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.